Skip to content

Clinical trials

Phase 4 Hepatitis C, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 4 Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20046
20051
20072
20081
20091
20113
20132
20141
20152
20163
20174
20183
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Unknown status4
Withdrawn3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche12
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Center For Hepatitis C, Atlanta, GA2
Duke University2
Massachusetts General Hospital2
University of California, San Francisco2
Catherine Anne Chappell1
Chronic Liver Disease Foundation1
Community Research Initiative of New England1
Elizabeth Krans, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic38
Hepatitis C12
Fibrosis4
Acquired Immunodeficiency Syndrome2
Anemia, Hemolytic2
Hemolysis2
Hepatitis, Chronic2
Kidney Failure, Chronic2
Opioid-Related Disorders2
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.